Documento de consensoPropuesta de protocolo para el informe histológico del tumor primario de los pacientes con un melanoma cutáneo del Grupo de Trabajo para el Melanoma Cutáneo de la Comunidad ValencianaProtocol proposal for the histological report of the primary tumor in patients with cutaneous melanoma from the task force for cutaneous melanoma of the valencian community
Bibliografía (53)
- et al.
Low- and high-risk malignant melanoma-I. Evaluation of clinical and histological prognosticators in 585 cases
Eur J Cancer Clin Oncol
(1983) - et al.
Influence of gender on survival in patients with stage I malignant melanoma
J Am Acad Dermatol
(1992) - et al.
Factores pronósticos en el melanoma maligno cutáneo localizado: estudio de 639 pacientes
Med Clin (Barc)
(2005) - et al.
Prognosticators of melanoma, the melanoma report, and the sentinel lymph node
Mod Pathol
(2006) - et al.
The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification
Pathology
(1986) - et al.
The histogenesis and biologic behavior of primary human malignant melanomas of the skin
Cancer Res
(1969) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
Ann Surg
(1970)- et al.
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system
J Clin Oncol
(2001) Malignant melanoma. Amultivariate analysis of prognostic factors
Pathol Annu
(1989)- et al.
Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3,661 patients from a single center
Cancer
(2003)
Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study
Int J Cancer
Predicting five-year outcome for patients with cutaneous melanoma in a population-based study
Cancer
Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?
Cancer
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
J Clin Oncol
Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden
J Natl Cancer Inst
Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review
Melanoma Res
A long-term analysis of 1,018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging
Surgery
Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland
Int J Cancer
Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation
Br J Cancer
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma
Surgery
Prognostic factors in 1,521 melanoma patients with distant metastases
J Am Coll Surg
Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival
Cancer
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
Cancer
Malignant melanoma. Prognostic significance of «microscopic satellites» in the reticular dermis and subcutaneous fat
Ann Surg
Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982
Cancer
Tumor progression, early diagnosis and prognosis of melanoma
Acta Oncol
Cited by (7)
Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients
2018, ChestCitation Excerpt :Every participant completed a standardized protocol including cardiovascular and respiratory history and self-reported symptoms (witnessed apneas, chronic snoring, presence of daytime hypersomnia, sleep duration, and presence of insomnia). The following data were also recorded with respect to the melanoma: the histologic type (superficial spreading, nodular, lentigo maligna, acral lentiginous, or others/unspecified); tumoral thickness (Breslow index, in mm); the histologic presence of ulceration, regression, and the mitotic index (number of mitoses per mm2)17; and tumoral stage in accordance with the 7th edition of the staging classification system of the American Joint Committee on Cancer.18 The tumor was subsequently categorized as localized, locoregional, or distant.
Sentinel lymph node status in melanoma: Prognostic value in a tertiary hospital and correlation with mitotic activity
2014, Actas Dermo-SifiliograficasCitation Excerpt :Regression was considered to be present when an inflammatory infiltrate was observed in over 50% of the lesion, with accompanying fibrosis (even if this was less prominent). The dermatopathologist systematically recorded the following information: diagnosis, tumor thickness (Breslow thickness in mm), presence of ulceration, mitotic rate, margin involvement, depth of invasion (Clark level),7 histologic subtype, presence of regression, T stage, and presence of vertical growth.13 SLN biopsy was performed following the preoperative intradermal injection of the radionuclide technetium 99 (Nancol, Molypharma, S.A.) in the peritumoral area on the day of the procedure, with detection by a gamma camera and subsequent gamma probe examination (Navigator GPS, Dynasil Corp.).
Assessment of regression in successive primary melanomas
2014, Actas Dermo-SifiliograficasEpidermal effacement in malignant melanoma
2011, Actas Dermo-SifiliograficasMultiple primary melanoma
2009, Actas Dermo-Sifiliograficas